These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10537048)
1. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. Maroney AC; Finn JP; Bozyczko-Coyne D; O'Kane TM; Neff NT; Tolkovsky AM; Park DS; Yan CY; Troy CM; Greene LA J Neurochem; 1999 Nov; 73(5):1901-12. PubMed ID: 10537048 [TBL] [Abstract][Full Text] [Related]
2. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis. Bozyczko-Coyne D; O'Kane TM; Wu ZL; Dobrzanski P; Murthy S; Vaught JL; Scott RW J Neurochem; 2001 May; 77(3):849-63. PubMed ID: 11331414 [TBL] [Abstract][Full Text] [Related]
3. CEP-1347/KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo. Glicksman MA; Chiu AY; Dionne CA; Harty M; Kaneko M; Murakata C; Oppenheim RW; Prevette D; Sengelaub DR; Vaught JL; Neff NT J Neurobiol; 1998 Jun; 35(4):361-70. PubMed ID: 9624618 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons. Harris CA; Deshmukh M; Tsui-Pierchala B; Maroney AC; Johnson EM J Neurosci; 2002 Jan; 22(1):103-13. PubMed ID: 11756493 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of aberrant and constitutive phosphorylation of the high-molecular-mass neurofilament subunit by CEP-1347 (KT7515), an inhibitor of the stress-activated protein kinase signaling pathway. O'Ferrall EK; Robertson J; Mushynski WE J Neurochem; 2000 Dec; 75(6):2358-67. PubMed ID: 11080187 [TBL] [Abstract][Full Text] [Related]
16. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation. Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705 [TBL] [Abstract][Full Text] [Related]
17. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS; Brown EM; Miller MS; Carswell S J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541 [TBL] [Abstract][Full Text] [Related]
18. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. Saporito MS; Thomas BA; Scott RW J Neurochem; 2000 Sep; 75(3):1200-8. PubMed ID: 10936203 [TBL] [Abstract][Full Text] [Related]
19. CEP-1347/KT7515, a JNK pathway inhibitor, supports the in vitro survival of chick embryonic neurons. Borasio GD; Horstmann S; Anneser JM; Neff NT; Glicksman MA Neuroreport; 1998 May; 9(7):1435-9. PubMed ID: 9631443 [TBL] [Abstract][Full Text] [Related]
20. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways. Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]